According to a new market
research report published by Global Market Estimates, the Global Clinical
Diagnostic Market is projected to grow at a CAGR of 6.5% from 2022 to 2027.
Major driving factors include
changes in the lifestyle of individuals who lead unhealthy lives, which has
resulted in a surge in diabetes, hypertension, and other cardiovascular
problems, as well as continued advancement in the industry and the advent of
contemporary apparatus.
Browse 153 Market Data
Tables and 113 Figures spread through 185 Pages and in-depth TOC on “Global Clinical
Diagnostic Market - Forecast to 2027’’ https://www.globalmarketestimates.com/market-report/clinical-diagnostic-market-3820
Abbott Laboratories, Becton, Dickinson and Company, BioMerieux, Bio-Rad
Laboratories Inc., Danaher Corporation, Siemens AG, Hologic Inc., Qiagen NV, F.
Hoffmann-La Roche AG, Thermo Fisher Scientific, and Quest Diagnostics Inc.,
among others, are some of the key players in the global clinical diagnostic
market.
Type
Outlook (Revenue, USD Billion, 2022-2027)
·
Lipid Panel
·
Liver Panel
·
Renal Panel
·
Complete Blood Count
·
Electrolyte Testing
·
Infectious Disease
Testing
Application
Outlook (Revenue, USD Billion, 2022-2027)
·
Instruments
·
Reagents
End-User
Outlook (Revenue, USD Billion, 2022-2027)
·
Hospital
Laboratory
·
Diagnostic
Laboratory
·
Point-of-care
Testing
Regional Outlook (Revenue, USD Billion, 2022-2027)
North America
Europe
Asia Pacific
Central & South America
Middle East & Africa
Contact:
Yash Jain
Email
address: yash.jain@globalmarketestimates.com
Phone
Number: +1 6026667238